This is the authors' abstract. We don't add key points for this paper.
The findings of this genetic association study suggest that preexisting TP53 CHIP variants may be associated with t-MNs after rucaparib treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kwan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: